Structure based on 2fye

Ideal structure
Name: n-[(1r)-1-[({[(5s)-3,5-dimethyl-2,5-dihydroisoxazol-4-yl]methyl}sulfonyl)methyl]-2-oxo-2-({(1s)-3-phenyl-1-[2-(phenylsulfonyl)ethyl]propyl}amino)ethyl]morpholine-4-carboxamide
Formula: C31 H42 N4 O8 S2
Weight: 662.817
SMILES: "C[CH]1ONC(=C1C[S](=O)(=O)C[CH](NC(=O)N2CCOCC2)C(=O)N[CH](CCc3ccccc3)CC[S](=O)(=O)c4ccccc4)C"
Spacial conformation based on PDB 2fye
RESIDUE   BCQ     87
CONECT      N3     3 C2   C4   C1  
CONECT      O6     2 C3   C5  
CONECT      C2     4 N3   C3   H21  H22 
CONECT      C3     4 O6   C2   H31  H32 
CONECT      C4     4 N3   C5   H41  H42 
CONECT      C5     4 O6   C4   H51  H52 
CONECT      C1     3 N3   O1   N   
CONECT      O1     1 C1  
CONECT      N      3 C1   CA   HN  
CONECT      CA     4 N    C    C03  HA  
CONECT      O      1 C   
CONECT      C      3 CA   O    N2  
CONECT      C03    4 CA   S04  H031 H032
CONECT      C09    4 S04  C12  H091 H092
CONECT      S04    4 C03  C09  O05  O06 
CONECT      C12    3 C09  C16  C13 
CONECT      C16    4 C12  C18  O15  H16 
CONECT      C13    3 C12  C17  N14 
CONECT      C18    4 C16  H181 H182 H183
CONECT      C17    4 C13  H171 H172 H173
CONECT      N14    3 C13  O15  HN14
CONECT      O15    2 C16  N14 
CONECT      O05    1 S04 
CONECT      O06    1 S04 
CONECT      N2     3 C    CA2  HN2 
CONECT      CA2    4 N2   CB2  CT   HA2 
CONECT      CB2    4 CA2  CB8  HB21 HB22
CONECT      CG2    3 CD1  CD2  CB8 
CONECT      CD1    3 CG2  CE1  HD1 
CONECT      CD2    3 CG2  CE2  HD2 
CONECT      CE1    3 CD1  CZ   HE1 
CONECT      CE2    3 CD2  CZ   HE2 
CONECT      CZ     3 CE1  CE2  HZ  
CONECT      CB8    4 CB2  CG2  HB81 HB82
CONECT      C7A    4 CT   S1   H7A1 H7A2
CONECT      CT     4 CA2  C7A  HT1  HT2 
CONECT      C4A    3 C3A  C5A  S1  
CONECT      C1A    3 C2A  C6A  H1A 
CONECT      C2A    3 C1A  C3A  H2A 
CONECT      C3A    3 C4A  C2A  H3A 
CONECT      C5A    3 C4A  C6A  H5A 
CONECT      C6A    3 C1A  C5A  H6A 
CONECT      S1     4 C7A  C4A  O1A  O2  
CONECT      O1A    1 S1  
CONECT      O2     1 S1  
CONECT      H21    1 C2  
CONECT      H22    1 C2  
CONECT      H31    1 C3  
CONECT      H32    1 C3  
CONECT      H41    1 C4  
CONECT      H42    1 C4  
CONECT      H51    1 C5  
CONECT      H52    1 C5  
CONECT      HN     1 N   
CONECT      HA     1 CA  
CONECT      H031   1 C03 
CONECT      H032   1 C03 
CONECT      H091   1 C09 
CONECT      H092   1 C09 
CONECT      H16    1 C16 
CONECT      H181   1 C18 
CONECT      H182   1 C18 
CONECT      H183   1 C18 
CONECT      H171   1 C17 
CONECT      H172   1 C17 
CONECT      H173   1 C17 
CONECT      HN14   1 N14 
CONECT      HN2    1 N2  
CONECT      HA2    1 CA2 
CONECT      HB21   1 CB2 
CONECT      HB22   1 CB2 
CONECT      HD1    1 CD1 
CONECT      HD2    1 CD2 
CONECT      HE1    1 CE1 
CONECT      HE2    1 CE2 
CONECT      HZ     1 CZ  
CONECT      HB81   1 CB8 
CONECT      HB82   1 CB8 
CONECT      H7A1   1 C7A 
CONECT      H7A2   1 C7A 
CONECT      HT1    1 CT  
CONECT      HT2    1 CT  
CONECT      H1A    1 C1A 
CONECT      H2A    1 C2A 
CONECT      H3A    1 C3A 
CONECT      H5A    1 C5A 
CONECT      H6A    1 C6A 
END   
HET    BCQ             87
HETNAM     BCQ N-[(1R)-1-[({[(5S)-3,5-DIMETHYL-2,5-DIHYDROISOXAZOL-4-Y
HETNAM   2 BCQ L]METHYL}SULFONYL)METHYL]-2-OXO-2-({(1S)-3-PHENYL-1-[2-
HETNAM   3 BCQ (PHENYLSULFONYL)ETHYL]PROPYL}AMINO)ETHYL]MORPHOLINE-4-C
HETNAM   4 BCQ ARBOXAMIDE
FORMUL      BCQ    C31 H42 N4 O8 S2

This OCA MONOMER page
uses Jmol, developed by the Jmol Development Team (color reference)
OCA© by Jaime Prilusky, 1996-2004,2006,2010,2014
Bioinformatics Unit
Weizmann Institute of Science